Thus, examining the RNA or protein quantification of eIF6 could contribute to predict the occurrence of HCC, and directly targeting eIF6 by genetic interference technique might improve therapeutic efficacy. The gene discussed is EIF6; the disease is hepatocellular carcinoma.